Skip to main content
NPS MedicineWise
20 Years Of Helping Australians To Make The Best Decisions About Medicines And Medical Tests

20 Years Of Helping Australians Make Better Decisions About Medicines, Medical Tests And Other Health Technologies.

  • Log In
  • Log in
  • SearchSearch
  • My AccountMy Account
  • SubscriptionsSubscriptions
  • FavouritesFavourites
  • SearchSearch
Close drawer

Log in

Signing you in

OR
Login Form

Forgot your password?

Forgot password

Forgot password

« Back to log in

Set new password

Reset Password

« Back to log in

Account exists

We found an existing account for

Would you like to:

Please log in below to connect your account.

LogIn after reset password

Forgot your password?

« Back to log in

Sign up

Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.

Signup details
Your details

My account

My account details

Log in details

–

change email

change password

My subscriptions

Add subscriptions

My favourites

You have not selected any filters.

Search

Alert

Log in to get email alerts for articles that match your past search terms.
We’ll send you email alerts for articles that match these search terms:

History

Log in to view your search history.
  • Search
  • Home
  • Medical Info
    Medical Info HomeClinical TopicsHealth TopicsConsumer InfoMedicine Finder
  • CPD
    CPD HomeGPsPharmacistsNursesStudents
    • Australian Prescriber
    • RADAR
    • MedicineInsight

RADAR

  • All Articles

Subscribe to RADAR

Subscribe to other NPS MedicineWise information
Privacy and terms
Breadcrumbs
  1. RADAR
  2. NPS RADAR April 2006

Article Sections

View allView all
  1. This issue is available in PDF format only.

NPS RADAR April 2006

  • 1 Apr 2006
  • 1 min read
  • Article
  • Related
Saved to favourites

  • Share to:

  • Download PDF

This issue is available in PDF format only.

Full reviews

Ezetimibe with simvastatin (Vytorin) for dyslipidaemia

Eplerenone (Inspra) for use after acute myocardial infarction complicated by heart failure



In Brief

Latanoprost with timolol combination eye drops

Metformin extended-release formulation

Calcium and risedronate combination pack for osteoporosis

New indications for ezetimibe and ezetimibe with simvastatin

Fenofibrate review updated with FIELD study evidence


Related Articles

Expand

Close

RADAR
  • About RADAR
  • Contact us
Date published: 1 April 2006
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.

Footer

NPS MedicineWise
FacebookTwitterLinkedInYouTubeInstagram
HONcode logo. This website is certified by Health On the Net Foundation. Click to verify.Logo stating that NPS are ISO-9001 certified by Global-Mark
About usServicesContact usMediaNewsCareersOrderTranslated infoAccessibilityCopyrightTerms of usePrivacy

© 2018 NPS MedicineWise. Providing independent, evidence-based information for the Australian Capital Territory (ACT), New South Wales, Northern Territory, Queensland, South Australia, Tasmania, Victoria and Western Australia.

PO Box 1147 Strawberry Hills NSW 2012Level 7, 418A Elizabeth St, Surry Hills NSW 2010ABN: 61 082 034 393HONcode logo. This website is certified by Health On the Net Foundation. Click to verify.Logo stating that NPS are ISO-9001 certified by Global-Mark

Programs funded by:

Australian Government - Department of Health

Our other initiatives:

VentureWise - Part of the MedicineWise Group
Choosing Wisely Australia - An initiative of NPS MedicineWise

Consumers: Talk to a professional (Monday – Friday, 9am – 5pm AEST)

Medicines Line

Get medicines information:

1300 MEDICINE
(1300 633 424) Calls triaged by healthdirect Australia

Adverse Medicine Events Line

Report a problem with medicines, medical devices or vaccines:

1300 134 237Online via the Therapeutic Goods Administration